158 related articles for article (PubMed ID: 9202761)
1. MeIQx-DNA adduct formation in rodent and human tissues at low doses.
Turteltaub KW; Mauthe RJ; Dingley KH; Vogel JS; Frantz CE; Garner RC; Shen N
Mutat Res; 1997 May; 376(1-2):243-52. PubMed ID: 9202761
[TBL] [Abstract][Full Text] [Related]
2. Dose-response studies of MeIQx in rat liver and liver DNA at low doses.
Frantz CE; Bangerter C; Fultz E; Mayer KM; Vogel JS; Turteltaub KW
Carcinogenesis; 1995 Feb; 16(2):367-73. PubMed ID: 7859370
[TBL] [Abstract][Full Text] [Related]
3. Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low dose.
Mauthe RJ; Dingley KH; Leveson SH; Freeman SP; Turesky RJ; Garner RC; Turteltaub KW
Int J Cancer; 1999 Feb; 80(4):539-45. PubMed ID: 9935154
[TBL] [Abstract][Full Text] [Related]
4. Analysis and quantification of DNA adducts of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in liver of rats by liquid chromatography/electrospray tandem mass spectrometry.
Paehler A; Richoz J; Soglia J; Vouros P; Turesky RJ
Chem Res Toxicol; 2002 Apr; 15(4):551-61. PubMed ID: 11952342
[TBL] [Abstract][Full Text] [Related]
5. Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses.
Turteltaub KW; Dingley KH; Curtis KD; Malfatti MA; Turesky RJ; Garner RC; Felton JS; Lang NP
Cancer Lett; 1999 Sep; 143(2):149-55. PubMed ID: 10503895
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the DNA adduction and pharmacokinetics of PhIP and MeIOx in rodents at doses approximating human exposure using the technique of accelerator mass spectrometry (AMS) and 32P-postlabeling.
Turteltaub KW; Vogel JS; Frantz C; Felton JS; McManus M
Princess Takamatsu Symp; 1995; 23():93-102. PubMed ID: 8844800
[TBL] [Abstract][Full Text] [Related]
7. Effect of N-acetyltransferase 2 polymorphism on tumor target tissue DNA adduct levels in rapid and slow acetylator congenic rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline.
Metry KJ; Neale JR; Bendaly J; Smith NB; Pierce WM; Hein DW
Drug Metab Dispos; 2009 Nov; 37(11):2123-6. PubMed ID: 19666988
[TBL] [Abstract][Full Text] [Related]
8. Formation and removal of DNA adducts in the liver of rats chronically fed the food-borne carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Hirose M; Wakabayashi K; Ochiai M; Kushida H; Sato H; Sugimura T; Nagao M
Jpn J Cancer Res; 1995 Jun; 86(6):516-22. PubMed ID: 7622414
[TBL] [Abstract][Full Text] [Related]
9. DNA adducts formed by 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat liver: dose-response on chronic administration.
Yamashita K; Adachi M; Kato S; Nakagama H; Ochiai M; Wakabayashi K; Sato S; Nagao M; Sugimura T
Jpn J Cancer Res; 1990 May; 81(5):470-6. PubMed ID: 2116395
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450-mediated metabolism and DNA binding of 2-amino-1,7-dimethylimidazo[4,5-g]quinoxaline and its carcinogenic isomer 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in mice.
Turesky RJ; Bessette EE; Dunbar D; Liberman RG; Skipper PL
Chem Res Toxicol; 2012 Feb; 25(2):410-21. PubMed ID: 22118226
[TBL] [Abstract][Full Text] [Related]
11. Possible relationship between tissue distribution of DNA adducts and genotoxicity of food-derived heterocyclic amines.
Thorgeirsson SS; Davis CD; Schut HA; Adamson RH; Snyderwine EG
Princess Takamatsu Symp; 1995; 23():85-92. PubMed ID: 8844799
[TBL] [Abstract][Full Text] [Related]
12. Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats.
Dingley KH; Freeman SP; Nelson DO; Garner RC; Turteltaub KW
Drug Metab Dispos; 1998 Aug; 26(8):825-8. PubMed ID: 9698300
[TBL] [Abstract][Full Text] [Related]
13. Benzene metabolism in rodents at doses relevant to human exposure from urban air.
Turteltaub KW; Mani C
Res Rep Health Eff Inst; 2003 Feb; (113):1-26; discussion 27-35. PubMed ID: 12675491
[TBL] [Abstract][Full Text] [Related]
14. Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenic activation of MeIQx in cynomolgus monkeys in vitro reflects low DNA adduct levels in vivo.
Davis CD; Schut HA; Adamson RH; Thorgeirsson UP; Thorgeirsson SS; Snyderwine EG
Carcinogenesis; 1993 Jan; 14(1):61-5. PubMed ID: 8425272
[TBL] [Abstract][Full Text] [Related]
15. Presence of N2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (dG-C8-MeIQx) in human tissues.
Totsuka Y; Fukutome K; Takahashi M; Takahashi S; Tada A; Sugimura T; Wakabayashi K
Carcinogenesis; 1996 May; 17(5):1029-34. PubMed ID: 8640908
[TBL] [Abstract][Full Text] [Related]
16. Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine.
Turesky RJ; Rossi SC; Welti DH; Lay JO; Kadlubar FF
Chem Res Toxicol; 1992; 5(4):479-90. PubMed ID: 1391614
[TBL] [Abstract][Full Text] [Related]
17. Induction of DNA-adducts and increase of 8-hydroxy-2-deoxyguanosine, but no development of preneoplastic lesions in offspring liver with transplacental and trans-breast milk exposure to 2-amino-3,8-dimethylimidazo [4,5-f ]quinoxaline (MeIQx) in rats.
Ichihara T; Wanibuchi H; Totsuka Y; Morimura K; Wei M; Nakae D; Fukushima S
Cancer Sci; 2004 Dec; 95(12):943-8. PubMed ID: 15596042
[TBL] [Abstract][Full Text] [Related]
18. Stability and reactivity of 2-nitrosoamino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Lakshmi VM; Hsu FF; Schut HA; Zenser TV
Chem Res Toxicol; 2006 Feb; 19(2):325-33. PubMed ID: 16485910
[TBL] [Abstract][Full Text] [Related]
19. Excretion of food-derived heterocyclic amine carcinogens into breast milk of lactating rats and formation of DNA adducts in the newborn.
Ghoshal A; Snyderwine EG
Carcinogenesis; 1993 Nov; 14(11):2199-203. PubMed ID: 8242844
[TBL] [Abstract][Full Text] [Related]
20. Identification of N2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethyl-imidazo[4,5- f]quinoxaline 3',5'-diphosphate, a major DNA adduct, detected by nuclease P1 modification of the 32P-postlabeling method, in the liver of rats fed MeIQx.
Ochiai M; Nagaoka H; Wakabayashi K; Tanaka Y; Kim SB; Tada A; Nukaya H; Sugimura T; Nagao M
Carcinogenesis; 1993 Oct; 14(10):2165-70. PubMed ID: 8222070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
